Coca-Cola Beverages hopes for a hot debut in July

Article Abstract:

Coca-Cola Beverages PLC, the biggest bottler of carbonated soft drinks in central and eastern Europe, expects to have a hot debut during its listing in London, UK, on Jul. 13, 1998, and in Sydney, Australia, on Jul. 14, 1998. The company is expected to be worth between 1.3 million pounds sterling to 1.7 billion pounds sterling because the price range for its initial public offering has been pegged at 125 pence to 160 pence ($2.09 to $2.68) per share. Coca-Cola Beverages is a spin-off of Australia-based Coca-Cola Amatil Ltd.'s operations in central and eastern Europe, plus bottling operations in northern and central Italy.

Comment:

Expects to have a hot debut during its listing in Sydney, Australia, on 7/14/98

Australia, Canned & Bottled Soft Drinks, Soft Drink Manufacturing, Organizational history, Soft drinks, Coca-Cola Beverages PLC

Friends Provident may acquire L&M for $1.2 billion

Article Abstract:

Friends Provident tendered an agreed bid of 744 sterling pounds to acquire Exeter, UK life insurer and pensions company London & Manchester PLC to spark rumors about renewed consolidation of the British insurance industry. One analyst felt that Friends may be beaten by another bidder based on the present offer. Analysts generally feel that consolidation would be a healthy trend. Friends Chairman David Newbigging noted that the takeover would allow Friends to gain higher capacity for boosting efficiency, expansion, and improve its market position.

Comment:

Tenders agreed bid of 744 sterling pounds to acquire Exeter, UK life insurer and pensions company London & Manchester PLC

Asset sales & divestitures, Acquisitions & mergers, Life Insurance, Direct Life Insurance Carriers, London and Manchester Group PLC, Friends Provident Life Office

Ex-Merck executive to lead Shire in bid to be 'more global.'(Shire Pharmaceuticals PLC, new chief executive)

Article Abstract:

Shire Pharmaceuticals PLC has named Matthew Emmens as its new chief executive. The 51-year old Emmens is a former marketing executive with Merck and Co.

Executive changes & profiles, Officials and employees, Pharmaceutical industry, Appointments, resignations and dismissals, Chief executive officers, Shire Pharmaceuticals Group PLC, Emmens, Matthew